CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Test Lens 1 +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00762970
NCT00762970N/ACompleted

Controlling Myopia Progression With Soft Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Sep 30, 2008·Updated Jun 19, 2018

In Brief

A clinical study evaluating Test Lens 1, Test Lens 2, and 1 other intervention for Myopia. Completed, enrolled 150 participants across 1 site.

Detailed Summary

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 30, 2008
Enrollment StartApr 1, 2007
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.8 years ago

Interventions

Test Lens 1device

Investigational soft contact lens with asperic optical design to control myopia progression.

Test Lens 2device

Investigational soft contact lens with asperic optical design to control myopia progression.

Control Lensdevice

Spectacle Lenses.